Frank Mazzotta, DO
Family Medicine · Williamsport, PANPI 1588618730
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,901 and has fallen 98.8% since, to $24 in 2025.
Across 207 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$616
- Novo Nordisk$599
- GSK$252
- Pfizer$246
- Amarin Pharma, Inc.$208
- Johnson & Johnson$195
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,18199%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $616 |
| Novo Nordisk | 43 | $599 |
| GSK | 14 | $252 |
| Pfizer | 22 | $246 |
| Amarin Pharma, Inc. | 17 | $208 |
| Johnson & Johnson | 6 | $195 |
| AbbVie(2 entities) | 10 | $138 |
| Novartis | 8 | $103 |
| Astellas Pharma US Inc | 5 | $101 |
| Boehringer Ingelheim | 6 | $99 |
| Merck | 6 | $77 |
| Amgen(2 entities) | 5 | $72 |
| Lilly USA, LLC | 4 | $62 |
| Optos, Inc. | 1 | $48 |
| Teva Pharmaceuticals USA, Inc. | 3 | $37 |
| Abbott | 2 | $36 |
| Gilead | 2 | $34 |
| Circassia Inc. | 2 | $31 |
| Genentech USA, Inc. | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Alkermes, Inc. | 1 | $24 |
| Harmony Biosciences LLC | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $16 |
| Bayer | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVOKANA$120
- Xultophy 100/3.6$113
How this compares
$3,207 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Williamsport
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.